- Benchmark ASINB0F3JBFY6C
- MarketplaceUS
- Category ID8297530011
- Analyzed Products
- Keywordlab supplies, safety supplies
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-25
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，结论很明确。 目前只有 1 个新品牌 Greetmed，2 个新发布里 1 个赚钱、1 个不赚钱，表面成功率 50%，但样本太小，而且真正跑通的只有靠功能差异化的那一款，不是可复制的宽市场机会；同时没有看到品牌洪流式涌入，暂时不是“30+ 新品牌”那种典型过度饱和，但已经很明显是同质化会死、差异化才可能活的窄门市场。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing这个市场现在不值得进入。 现有数据只看到 1 个新品牌 Greetmed 的样本：一个新款 ASIN B0F3JBFY6C 赚钱，另一个新款 ASIN B0FVDMSQHR 不赚钱，说明这个细分里不是“稳定赚钱”，而是靠少数差异化产品硬打出来的局部机会；但从产品形态看，普通同质款已经直接失败，市场更像是低差异化、竞争挤压明显的赛道。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):50.00%Which new brands have these successful new listings?Alternatives- 普通凡士林纱布/石蜡纱布：通常比Xeroform敷料更便宜、在药房和电商更容易买到，适合需要“防粘连+保湿”但不想为含药配方付费的用户。
- 不含碘仿/不含药性的非粘附油纱：如果用户只是想减少换药时粘连和疼痛，这类基础敷料通常更容易接受，且对部分担心药物成分的人更友好。
- 硅凝胶网状敷料（non-adherent silicone mesh）：使用门槛低、换药时舒适度高，很多情况下可替代高价医用特殊敷料；对家庭护理和小面积创面更具可及性。
- 水凝胶敷料/水凝胶片：在干燥创面、轻度烧烫伤或需要湿性愈合时，往往是更容易理解和操作的替代方案，价格区间也常更宽。
- 预涂凡士林的无菌纱布片/油纱片：对于临时伤口覆盖、轻度擦伤或应急包，往往比专门的Xeroform敷料更容易买到，也更适合预算敏感用户。
- 标准无菌纱布+外层凡士林或创面护理膏的组合：当用户不想购买专用成品敷料时，这种DIY组合通常成本更低、补货更灵活，适合家庭常备。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场目前不能进，结论很明确：不是适合小品牌切入的机会，且现有样本显示新入场者只有50%成功、50%失败，已经有明显的价格/差异化压力。 现有能赚钱的案例并不强：Greetmed 的成功款 B0F3JBFY6C 只是在“老型号基础上做功能差异化”，但失败款 B0FVDMSQHR 说明一旦只是做常规同质化油纱，基本就会直接沉没。
Least investment in new productsMost investment in new productsNew products with Highest revenueGreetmed
Recent Monthly Revenue (USD):$2,199.00(100pcs/month)B0F3JBFY6C (4.7/5 (115 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0F3JBFY6C (4.7/5 (115 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0FVDMSQHRBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入：目前只有 Greetmed 这一家新品牌在跑通，样本里新品牌盈利率 50%，但同时也有 50% 的新产品失败，说明不是稳定机会，而是靠单品差异化硬撑。更关键的是，真正跑出来的只有 B0F3JBFY6C 一款：28.11% 利润率、月销 100、月营收 $2,199、115 条评论；另一款 B0FVDMSQHR 则是无销量、无利润、直接失败。
证据很明确：B0F3JBFY6C 的成功点不是价格战，而是“基于旧款做功能差异化”——黄色独立包装、5"x9"大规格、不粘连、保湿、减痛，且是白帽新上架；早期投入约 $3,449，其中广告约 $776。对比之下，失败款 B0FVDMSQHR 只是常规 Xeroform 油纱，外观、功能都高度同质化，直接卖不动。这个市场当前没有出现你要警惕的 30+ 新品牌洪流，当前数据里只有 1 个新品牌，不构成“品牌爆量涌入”的过度饱和警报；但它已经显出低差异化就死、高差异化才活的门槛。对小商家来说，想复制成功，必须有明确功能创新和额外预算去做研发/包装/品牌，不是靠低成本铺货就能赢。对大品牌来说，这里也不是轻松盘子，因为高利润目前只集中在单一成功款上，且成功依赖具体功能卖点，不是自然形成的宽市场红利。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0F3JBFY6CGreetmed2025-08-31Yes$21.99100pcs$2199.028.11%$618.14Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0F3JBFY6CGreetmed2025-08-31Yes$21.99100pcs$2199.028.11%$618.14#New Product Success Rates
Listing这个市场不该进，至少对新小品牌来说不是好机会；它不是高增长市场，而是被旧产品逻辑和差异化门槛卡住的市场。 目前能站出来的只有一个新入场品牌 Greetmed，但它的成功样本只有 1 个盈利、1 个亏损，整体新产品盈利率只有 50%，这不代表可复制；更关键的是，真正盈利的 B0F3JBFY6C 其实是“基于旧ASIN做功能差异化”的路线，不是白手起家式新品。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
GreetmedNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Greetmed#Success Rate by Entry Time
Listing这个市场不适合现在进入，结论很直接：只有1个新品牌样本出现、成功率50%，但两条新发布产品里一条赚钱、一条不赚钱，说明不是机会清晰，而是结果极不稳定。 更关键的是，近几年几乎没有新增释放，只有2025年出现Greetmed的2个新产品，市场不是在放量扩张，而是样本稀少、验证不足；对你这种单个ASIN预算50万人民币来说，能做，但这不是一个“低风险可复制”的市场。
证据上看，Greetmed是唯一可追踪的新品牌案例：B0F3JBFY6C卖到21.99美元，月销100、月营收2199美元，利润率28.11%，靠的是“基于旧ASIN+功能差异化”，属于真正能跑通的新品；但同品牌的B0FVDMSQHR同样是新发布，却直接无销量、无盈利，说明这个赛道对差异化要求非常高，单纯做常规Xeroform配方不够。 从时间上看，2022-2024没有可见新发布，2025只冒出这两个样本，谈不上新品牌持续进入，也看不出市场增长，更像是少数产品偶发成功；同时，当前市场盈利产品占比50%，新发布盈利占比也是50%，远高于你设定的“<10%高风险”红线，但样本太小，不能当成宽松市场看待。
大品牌可以考虑，但必须按高投入、强差异化来做；小 business 不建议直接冲。 大品牌可跟的唯一明确案例是Greetmed的B0F3JBFY6C，预算至少按它的21.99美元零售价对应的中高客单来准备，而且还要额外预留研发/认证/品牌投入，因为这类医疗耗材不是靠前期铺货就能稳定赢；小 business 这边没有真正的低评论成功范例（两条样本都在115评论以内，且不是“众多小品牌成功”），更没有出现“新品牌大量成功”的迹象，所以不值得进场。
- 结论：不要进入，至少现在不进。
- 你若硬做，只能走强功能差异化，照着 B0F3JBFY6C / Greetmed 这种路线，而不是常规同质化产品。
- B0FVDMSQHR 是明确的反面样本：常规配方、无差异化、无销量，说明这个市场对平庸新品很残酷。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 1 0 0 1 2026 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 1 0 0 0 2025/9 0 0 0 0 0 0 0 1 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesGreetmedB0F3JBFY6C (4.7/5 (115 Reviews))Xeroform Petrolatum Dressing 5"x9" 25 Individual Pack Gauze Pads, Non-Adherent Mesh Sterile Guaze Pads for Wound Care, Burn Bandages Gauze Wrap for Wound Closure and Medical Supplies
This listing is deemed profitablePrice (USD)$21.99Released TypeNew Release (2025-08-31)Brand is a new entry in this marketSize and Weight20.6 x 12.5 x 4.2 cm, 331.00gProfitable Factors
Based on old ASINDistinct functions and featuresDesign & Appearance
黄色敷料片，视觉上比常见白色纱布更醒目, 5"x9"大片尺寸，且为独立单片包装，形态更偏向即用型创面敷料Key Buying Motive
含凡士林与3%溴化二苯铵，主打不粘连、保湿和换药减痛Target Customers
适合烧伤、术后切口、皮肤移植、创面渗出护理等需要不粘连敷料的人群Early Investment
Investment
Monthly Revenue (Recent) (USD)$2,199.00100 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight25.99% / 28.11%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight18.67% / 20.78%Peak / Non PeakSales & BSR Performance